MS Franchise A Surprising Concern For Sanofi In Q3; Dupixent Out-Performs

 
• By Lucie Ellis-Taitt
Pressure
Sanofi MS franchise under pressue after disappointing growth in Q3 • Source: Shutterstock

More from Earnings

More from Business